[go: up one dir, main page]

AU2001268442A1 - Identification of cdnas associated with benign prostatic hyperplasia - Google Patents

Identification of cdnas associated with benign prostatic hyperplasia

Info

Publication number
AU2001268442A1
AU2001268442A1 AU2001268442A AU6844201A AU2001268442A1 AU 2001268442 A1 AU2001268442 A1 AU 2001268442A1 AU 2001268442 A AU2001268442 A AU 2001268442A AU 6844201 A AU6844201 A AU 6844201A AU 2001268442 A1 AU2001268442 A1 AU 2001268442A1
Authority
AU
Australia
Prior art keywords
identification
benign prostatic
prostatic hyperplasia
cdnas associated
cdnas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268442A
Inventor
Robert H. Getzenberg
Prakash Kulkarni
William E. Munger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Ore Pharmaceuticals Inc
Original Assignee
Japan Tobacco Inc
Ore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc, Ore Pharmaceuticals Inc filed Critical Japan Tobacco Inc
Publication of AU2001268442A1 publication Critical patent/AU2001268442A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2001268442A 2000-06-20 2001-06-15 Identification of cdnas associated with benign prostatic hyperplasia Abandoned AU2001268442A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21272600P 2000-06-20 2000-06-20
US60212726 2000-06-20
PCT/US2001/019157 WO2001098456A2 (en) 2000-06-20 2001-06-15 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

Publications (1)

Publication Number Publication Date
AU2001268442A1 true AU2001268442A1 (en) 2002-01-02

Family

ID=22792193

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268442A Abandoned AU2001268442A1 (en) 2000-06-20 2001-06-15 Identification of cdnas associated with benign prostatic hyperplasia

Country Status (2)

Country Link
AU (1) AU2001268442A1 (en)
WO (1) WO2001098456A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001268570A1 (en) * 2000-06-16 2001-12-24 Millennium Pharmaceuticals, Inc. 33358, a novel human ankyrin family member and uses thereof
EP1565548A2 (en) * 2002-11-25 2005-08-24 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells
US7700334B2 (en) 2003-08-12 2010-04-20 Lawrence Livermore National Security, Llc Photoswitchable method for the ordered attachment of proteins to surfaces

Also Published As

Publication number Publication date
WO2001098456A2 (en) 2001-12-27
WO2001098456A3 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001259672A1 (en) Methods for the enzymatic assembly of polynucleotides and identification of polynucleotides having desired characteristics
AU2001236731A1 (en) Transurethral volume reduction of the prostate (tuvor)
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
SI0968208T1 (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002243446A1 (en) Method of making hydrofluorocarbons and hydrochlorofluorocarbons
AUPQ923100A0 (en) Treatment of prostate cancer
AU2001288360A1 (en) Genomics-assisted rapid identification of targets
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU2002219900A1 (en) Minimal identification of features
ZA991315B (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
AU2001268442A1 (en) Identification of cdnas associated with benign prostatic hyperplasia
AU2000279176A1 (en) Locking nail and target appliance
AU2001283152A1 (en) Identification of cdnas associated with benign prostatic hyperplasia
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2876000A (en) Tyrosine kinase inhibitors and methods of using the same
AU2002232403A1 (en) Del-1 and benign prostatic hyperplasia
GB0301016D0 (en) Treatment of benign prostatic hyperplasia
AU2002336520A1 (en) Method of treating benign prostatic hyperplasia and other beingn porstate conditions
AU2001235961A1 (en) Integrated optical devices and methods of making such devices
AU2002210683A1 (en) Identification of hla-dr restricted hcv epitopes
AU2002317553A1 (en) Genes associated with benign prostatic hyperplasia
AU2001278204A1 (en) Methods of selecting and cloning animals
GB2418985B (en) Protein markers for human benign prostatic hyperplasia(BPH)